Thalomid, also known by its drug name, Thalidomide, is a prescription medication approved by the Food and Drug Administration (FDA) to treat multiple myeloma. Thalomid is sometimes prescribed off-label to treat non-Hodgkin lymphoma after other therapies have failed.
Thalomid is an immunomodulator – a drug that modulates the immune system. It is unknown how Thalomid works to fight lymphoma.
How do I take it?
When taken for myeloma, Thalomid is taken orally on specific days in a 28-day cycle.
Thalomid comes in the form of a capsule.
The FDA-approved label for Thalomid lists common side effects including fatigue, fever, anxiety, agitation, confusion, dizziness, dry skin, trouble breathing, muscle weakness, tremors, nausea, constipation, loss of appetite, weight changes, neuropathy (pain, numbness, or tingling in the limbs), and blood clots.
Rare but serious side effects listed for Thalomid include fetal harm in pregnant women, heart attack, stroke, bradycardia (slowed heart rate), severe skin reactions, and hypersensitivity reactions.
For more details about this treatment, visit:
Thalomid – Celgene
Chemotherapy for Non-Hodgkin Lymphoma – American Cancer Society
Drug Therapy for Multiple Myeloma – American Cancer Society
We never share your personal information with anyone.